360 High-Risk Vulnerability Immunization Tool V2.0 vs Allgress Vulnerability Management: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Allgress Vulnerability Management

Mid-market and enterprise security teams drowning in scanner noise will benefit most from Allgress Vulnerability Management because it actually ties vulnerability findings to business impact instead of just listing CVE counts. The platform integrates directly with Qualys and Nessus data while forcing prioritization through risk workflows and asset context, which cuts the typical triage overhead by half. Skip this if your organization lacks mature asset inventory or expects point-and-click remediation orchestration; Allgress assumes you have basic hygiene in place and need help deciding what to fix first.